Sales revenues for April 2025

Sofia, Bulgaria, May 21, 2025 – According to the requirements of Art. 100t of the Law on Public Offering of Securities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies, that for April 2025 the Company recorded decrease in sales of 28% compared to the same month of the previous year, incl. 19% decrease in domestic sales and 34% decrease in export sales.

For the period from the beginning of 2025, the Company realized a 3% increase in sales, including 7% decrease in domestic sales and a 11% increase in export sales.